Targeting EphA2 with miR-124 mediates Erlotinib resistance in K-RAS mutated pancreatic cancer

Authors:

Abstract
No abstract available
Funding Information
  • Natural Science Foundation of Zhejiang Province (LQ17H160016)
  • Zhejiang Provincial Medical and Healthy Science and Technology Projects (2015KYA029)

This publication has 28 references indexed in Scilit: